STEAM and the Vaccination Race
The COVID-19 vaccines are a triumph of science and technology. This is, by far, the fastest a vaccine has ever been developed and deployed on a mass scale. Vaccines are now available to all over 16, and I recently received my second shot. I hope you’re getting yours, too, and I’m looking forward to greater activity in the coming months. It’s also looking like teenagers will be able to get the vaccine this summer, greatly increasing the probability of an in-person return to school in the Fall.
But make no mistake, we are in a race against the virus: we must vaccinate most of the country/world faster than the virus can spread and mutate into more resistant variants. So while there’s cause for optimism, time is critical. This makes the recent decision to pause (and likely, unpause) the Johnson & Johnson vaccine all the more frustrating.
There’s been vigorous debate on whether a full pause was the right approach. My fear is that this decision will reduce public confidence in this vaccine and the COVID-19 vaccines, in general. We were already starting to plateau in doses administered, as the “early adopters” have received theirs. Approximately 40% of adults have received at least one dose. We’re now at the stage of trying to vaccinate those who are difficult to reach or are more cautious, reluctant, or suspicious of the vaccine. What’s particularly frustrating is that the J&J is the better vaccine at this stage. It requires only a single dose, and it can be stored using normal refrigeration, not super cold storage. It is the best weapon against the virus for hard to reach areas and populations.
Of course, potentially catastrophic side effects must be taken seriously. And there were 6 reported cases of serious blood clots that may have been related to the J&J vaccine, with one death. Any of those incidents is tragic, and I feel for those affected, but that’s out of 7 million doses administered. That’s an extremely rare occurrence, and many times less than your chance of dying from COVID. But the CDC decided to pause the J&J out of “an abundance of caution”.
I understand the reasoning behind the pause. Ignoring potential side effects would have been catastrophic, also providing future fuel to vaccine deniers. It’s a difficult and terrible choice and complicated one. But this is where a perspective beyond the expertise of the members of the CDC’s Advisory Committee on Immunization Practices (physicians, scientists, and public health specialists) may have been beneficial.
|